- Your cart is empty
- Continue Shopping
With Trump in the U.K., GSK touts $30 billion investment in U.S. over 5 years
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45.LONDON — The U.K.-based drugmaker ...